Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
OABI
OABI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
OABI News
OmniAb Reports Strong Q1 2026 Performance, Raises Revenue Guidance
May 08 2026
seekingalpha
OmniAb (OABI) Q4 2025 Earnings Call Transcript
Mar 15 2026
NASDAQ.COM
OmniAb Q4 2025 Earnings Call Highlights
Mar 15 2026
Yahoo Finance
OmniAb Reports Q4 2025 Earnings with Growth Momentum
Mar 05 2026
seekingalpha
OmniAb Reports Q4 Earnings Miss with Revenue Decline
Mar 04 2026
seekingalpha
OmniAb Launches First Transgenic Chicken Platform, Expanding Therapeutic Opportunities
Dec 15 2025
Newsfilter
GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4
Dec 11 2025
Newsfilter
GT Biopharma Advances GTB-3650 Clinical Trial to Cohort 4 at 10μg/kg/day
Dec 11 2025
PRnewswire
OmniAb Signs Technology License and Services Agreement for Antibody Discovery with New Incubated Firm from ArrowMark Partners and Viking Global Investors
Nov 17 2025
Newsfilter
Three Health Care Stocks You Won't Want to Overlook This Quarter
Aug 26 2025
Benzinga
OmniAb Plans to Secure $30 Million Through Private Stock Offering
Aug 25 2025
SeekingAlpha
AI Is Quietly Reinventing Healthcare--And Real Deployments Are Now Underway
Jun 30 2025
Newsfilter
Benchmark Reiterates Buy on OmniAb, Maintains $6 Price Target
May 12 2025
Benzinga
OmniAb Reports First Quarter 2025 Financial Results and Business Highlights
May 08 2025
Newsfilter
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program
May 05 2025
Yahoo Finance
VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program
May 05 2025
Newsfilter
Show More News
